FEMY · NASDAQ
Femasys (FEMY) Stock Price & Fundamentals
Femasys (FEMY) closed at $405.74 on Oct 9, 2026, down 0.01% from the previous close of $405.78.
Share price, past year
1Y +12.85%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $405.74 |
| Sep 30, 2026 | $385.17 |
| Aug 31, 2026 | $380.86 |
| Jul 31, 2026 | $396.17 |
| Jun 30, 2026 | $365.16 |
| May 29, 2026 | $365.17 |
| Apr 30, 2026 | $381.19 |
| Mar 31, 2026 | $353.80 |
| Feb 27, 2026 | $333.70 |
| Jan 30, 2026 | $362.09 |
| Dec 31, 2025 | $370.34 |
| Nov 28, 2025 | $362.71 |
| Oct 31, 2025 | $376.60 |
Key statistics
- Market cap
- $1.23B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $2.30M
- Net income (TTM)
- −$11.77M
- Shares outstanding
- 3M
- Dividend yield
- —
- 52-week range
- $332.69 – $405.78
Femasys's market cap is $1.23B, based on a share price of $405.74 and 3M shares outstanding as of Jun 30, 2026.
Financials
Femasys reported revenue of $2.29M for fiscal 2025, up 40.77% from fiscal 2024.
Femasys reported a net loss of $18.63M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 6 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $2.29M | +40.8% | −$18.63M | −812.3% | −$9.40 | −$19.22M |
| FY2024ended Dec 31, 2024 | $1.63M | +52.0% | −$18.82M | −1,155.0% | −$17.00 | −$20.21M |
| FY2023ended Dec 31, 2023 | $1.07M | −11.1% | −$14.25M | −1,329.1% | −$18.60 | −$11.42M |
| FY2022ended Dec 31, 2022 | $1.21M | +2.3% | −$11.39M | −944.6% | −$19.20 | −$11.14M |
| FY2021ended Dec 31, 2021 | $1.18M | +13.7% | −$7.54M | −639.0% | −$22.40 | −$8.24M |
| FY2020ended Dec 31, 2020 | $1.04M | — | −$6.91M | −666.2% | −$144.00 | −$4.94M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $331.83K | −$4.47M | −$1.33 |
| Q1 FY2026ended Mar 31, 2026 | $424.89K | $846.10K | $0.00 |
| Q4 FY2025ended Dec 31, 2025 | $813.39K | −$3.95M | — |
| Q3 FY2025ended Sep 30, 2025 | $729.39K | −$4.19M | −$2.00 |
| Q2 FY2025ended Jun 30, 2025 | $409.27K | −$4.59M | −$3.18 |
| Q1 FY2025ended Mar 31, 2025 | $341.26K | −$5.90M | −$4.60 |
| Q4 FY2024ended Dec 31, 2024 | $581.58K | −$5.12M | — |
| Q3 FY2024ended Sep 30, 2024 | $554.91K | −$5.41M | −$4.80 |
Company profile
- Name
- Femasys Inc.
- Ticker
- FEMY
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 3950 Johns Creek Court, Suite 100, Suwanee, GA 30024
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001339005
Recent SEC filings
- Aug 14, 2026
- Aug 14, 2026
- Aug 11, 2026
- Jun 24, 2026
- Jun 24, 2026
- Jun 5, 2026
- Jun 4, 2026
- May 13, 2026
Frequently asked questions
What is Femasys's stock price?
Femasys (FEMY) closed at $405.74 on Oct 9, 2026, down 0.01% from the previous close of $405.78.
What is Femasys's market cap?
Femasys's market cap is $1.23B, based on a share price of $405.74 and 3M shares outstanding as of Jun 30, 2026.
How much revenue does Femasys make?
Femasys reported revenue of $2.29M for fiscal 2025, up 40.77% from fiscal 2024.
Does Femasys pay a dividend?
Femasys's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Femasys Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures